AstraZeneca Pharma India Ltd has announced that a meeting of the Board of Directors of the Company will be held on March 17, 2007, inter alia, to consider the following business:
1. To consider revocation of recommended Dividend for the year ended December 31, 2006.
2. To consider payment of Interim Dividend for the year ended December 31, 2006.
3. To consider the approval of the revised Audited Accounts for the financial year ended December 31, 2006, after incorporating necessary changes as to the revocation of recommended dividend and payment of Interim Dividend for period ended December 31, 2006 and to make consequential changes in the Notice for the AGM and the Directors’ Report.